Oryn Therapeutics Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
The company targets autoimmune and inflammatory diseases, infectious diseases, and cancer through these novel therapeutics, operating with a small team focused on advancing its programs. In June 2026, Oryn Therapeutics entered into a Catalyze agreement with Lilly ExploR&D to access scientific capabilities intended to accelerate its research and development efforts.